Evidence map›Paper›PMID 34491406›Full record

ArticleJournal of neurology2022

Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM.

Juan I Rojas, Agustín Pappolla, Patricio Blaya, Mariano Marrodán, María C Ysrraelit, Geraldine Luetic, Susana Liwacki, Andrés Barboza, Marcos Burgos, Leila Cohen and 22 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03375177 (Multiple Sclerosis Registry in Argentina), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03375177 unknown statusnot on this map

Multiple Sclerosis Registry in Argentina (RelevarEM)

Typeobservational_patient_registrySponsorHospital Italiano de Buenos AiresRan2018 to 2024Enrolled4,000ConditionsMultiple SclerosisArmsNatural history of disease
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 1 country.

Juan I RojasCentro de Esclerosis Múltiple de Buenos Aires, (CEMBA), Billinghurst 1611, CP 1181, Buenos Aires, Argentina. rojasjuanignacio@gmail.com.
Agustín PappollaHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Patricio BlayaNeurocomp, Trelew, Argentina.
Mariano MarrodánDepartment of Neurology, Fleni, Buenos Aires, Argentina.
María C YsrraelitDepartment of Neurology, Fleni, Buenos Aires, Argentina.
Geraldine LueticInstituto de Neurociencias de Rosario, Rosario, Argentina.
Susana LiwackiClínica Universitaria Reina Fabiola, Cordoba, Argentina.
Andrés BarbozaHospital Central de Mendoza, Mendoza, Argentina.
Marcos BurgosServicio de Neurología, Hospital San Bernardo, Salta, Argentina.
Leila CohenFacultad de Medicina - UBA, Centro Universitario de Esclerosis Múltiple, Hospital Dr. J. M. Ramos Mejía, CABA, Buenos Aires, Argentina.
Carolina MainellaHospital Español de Rosario, Santa Fe, Argentina.
Gisela ZangaUnidad Asistencial César Milstein, Buenos Aires, Argentina.
María L MenichiniSanatorio Británico, Rosario, Argentina.
Dario TavoliniINECO Neurociencias, Fundación INECO, Rosario, Argentina.
Verónica TkachukSección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.
Pablo LopezNeuroimmunology Unit, Department of Neuroscience, Hospital Aleman, Buenos Aires, Argentina.
Felisa LequizamonHospital de Agudos, Dr. Teodoro Álvarez, Buenos Aires, Argentina.
Eduardo KnorreHospital de Agudos, Dr. Teodoro Álvarez, Buenos Aires, Argentina.
Pedro NofalSanatorio Güemes, Buenos Aires, Argentina.
Liliana PatruccoHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Jimena MiguezHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Edgardo CristianoCentro de Esclerosis Múltiple de Buenos Aires, (CEMBA), Billinghurst 1611, CP 1181, Buenos Aires, Argentina.
Marcela FiolDepartment of Neurology, Fleni, Buenos Aires, Argentina.
Jorge CorrealeDepartment of Neurology, Fleni, Buenos Aires, Argentina.
María I GaitánDepartment of Neurology, Fleni, Buenos Aires, Argentina.
Ricardo AlonsoFacultad de Medicina - UBA, Centro Universitario de Esclerosis Múltiple, Hospital Dr. J. M. Ramos Mejía, CABA, Buenos Aires, Argentina.
Berenice SilvaFacultad de Medicina - UBA, Centro Universitario de Esclerosis Múltiple, Hospital Dr. J. M. Ramos Mejía, CABA, Buenos Aires, Argentina.
Orlando GarceaFacultad de Medicina - UBA, Centro Universitario de Esclerosis Múltiple, Hospital Dr. J. M. Ramos Mejía, CABA, Buenos Aires, Argentina.
Adriana CarráSección de Enfermedades Desmielinizantes, Hospital Británico, Buenos Aires, Argentina.
Nora Fernandez LiguoriSanatorio Güemes, Buenos Aires, Argentina.
Marina Alonso SerenaServicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Edgar Carnero ContenttiNeuroimmunology Unit, Department of Neuroscience, Hospital Aleman, Buenos Aires, Argentina.
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia · ARHospital Italiano de Buenos Aires · ARHospital Ramos Mejía · ARHelios Salud · ARHospital Alemán · ARHospital General de Agudos Dr. TEODORO ALVAREZ · ARInstituto de Neurología Cognitiva · ARCentro Científico Tecnólogico - Rosario · ARCentro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARHospital Británico de Buenos Aires · ARHospital César Milstein · ARHospital de Clínicas "José de San Martín" · ARHospital Provincial de Rosario · ARInstituto Cardiovascular de Buenos Aires · ARServicio Diabetología Hospital Córdoba · ARUniversity of Mendoza · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe aimed to analyze the accumulative risk of MRI and OB factors for evolution from RIS to MS in subjects included in the Argentinean MS registry (NCT03375177).

methodsRIS subjects were identified according to RIS diagnosis criteria. Subjects were longitudinally followed with clinical and MRI at intervals of 6 months. Time from RIS identification to the first clinical event was estimated using Kaplan-Meier. Multivariable Cox regression models were created to assess the independent predictive value of demographic characteristics, as well as clinical, OB and MRI data on time to the first clinical event. The single and increased risk factor of evolution of RIS was quantified.

resultsA total of 88 RIS subjects, mean follow-up time 42 ± 4 months were included. 39 (44.3%) and 23 (26.1%) had a new MRI lesion or a clinical event, respectively, during the follow-up. OB (HR 5.9, 95% CI 1.29-10.1, p = 0.004), infratentorial lesions (HR 3.7, 95% CI 1.09-7.5) and spinal cord lesions (HR 5.3, 95% CI 1.4-8.2, p = 0.01) at RIS identification were independent predictors associated with a subsequent clinical event. The accumulative risk showed that when two of the three factors (OB, infratentorial or spinal cord lesions) were present the HR was 10.4, 95% CI 4.4-22, p < 0.001, and when three factors were present, it was HR 15.6, 95% CI 5.7-28, p < 0.001 for a relapse.

conclusionThe presence of three factors significantly increased the risk of clinical event; high-risk subjects should probably be managed by a different approach than those used for individuals without high-risk factors.

Indexed as

Demyelinating DiseasesMultiple SclerosisArgentinaDisease ProgressionHumansMagnetic Resonance ImagingRegistriesArgentinaClinical progressionMultiple sclerosisRadiological activityRadiologically isolated syndromeRegistry

Identifiers

PMID34491406
OpenAlexW3198347332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.